Respiratory Devices Market Size, Share, Trends, Industry Analysis, and Forecast (2025 – 2031)

Respiratory Devices Market Size
The global respiratory devices market size was valued at $26.98 billion in 2025 and is projected to reach $39.36 billion by 2031, growing at a CAGR of 6.5% during the forecast period.

Respiratory Devices Market Overview
Respiratory devices play a crucial role in healthcare by enhancing pulmonary function, facilitating mucus clearance, and improving overall patient outcomes for those with respiratory conditions. These devices range from oxygen concentrators and nebulizers to mechanical ventilators and positive airway pressure devices, each designed to meet specific patient needs. 
Companies in the healthcare sector can benefit significantly from the growing demand for respiratory devices, especially as the prevalence of chronic respiratory diseases continues to rise globally. By investing in the development and distribution of innovative respiratory technologies, companies can not only capture a larger market share but also contribute to better patient care and outcomes. 
Additionally, the shift towards home respiratory care allows companies to tap into new markets, providing patients with convenient and cost-effective solutions that enhance their quality of life while reducing the burden on healthcare facilities. 

Respiratory Devices Market Dynamics
The respiratory devicesmarket is expected to witness significant growth in the future due to the rise in the incidence of respiratory diseases, increase in the geriatric population, and advancements in respiratory care technology. However, the stringent regulatory requirements, shortage of skilled professionals, and high cost are restraining the growth of the market.

Furthermore, rise in the need for home care therapeutic devices, increasing investments in R&D, and improving healthcare infrastructure are the key trends propelling the respiratory devices market. 

Increasing Incidence of Respiratory Diseasesis Driving the Respiratory Devices Market
The increasing incidence of respiratory diseases is significantly impacting the respiratory devicesmarket, by driving demand for effective diagnostic and therapeutic solutions. 
• For example, the World Health Organization reported in March 2023 that over 200 million individuals suffer from chronic obstructive pulmonary disease (COPD), which alone caused 3.23 million deaths in 2019. This alarming prevalence is prompting healthcare providers and device manufacturers to enhance their offerings. 
• Companies like Masimo are responding to this demand; on February 13, 2024, they launched an Over-the-Counter fingertip pulse oximeter, making it easier for patients to monitor their oxygen levels at home without a prescription. 
• Government initiatives also play a role; for instance, the CDC reported in September 2022 that there were 873,000 emergency department visits related to COPD in the U.S. in 2020, underscoring the healthcare system's burden and the necessity for improved respiratory care solutions. 
Overall, the growing burden of respiratory diseases is catalyzing market growth, prompting both private companies and public health entities to invest in advanced respiratory devices and testing methodologies.

By End-User, the Specialty Clinics Segment is projected to be the Largest Segment in the Respiratory Devices Market
Specialty Clinics is the largest segment in the respiratory devices market, driven by increasing prevalence of respiratory diseases and the rising demand for targeted, specialized care. These clinics, which focus on specific respiratory conditions, are becoming essential in providing tailored treatment plans and advanced monitoring, thus attracting investments from both private companies and government initiatives. 
• For example, in July 2022, the American Lung Association launched the ""Lung Health Action Plan,"" aimed at improving access to care for patients with respiratory conditions, which in turn encourages the establishment of more specialty clinics. 
• Companies like ResMed are also capitalizing on this trend; they introduced the AirSense 11 CPAP device in December 2021, which is designed for use in both home and specialty clinic settings, enhancing patient compliance and comfort. 
Furthermore, the demand for specialized diagnostic tools, such as polysomnography devices and advanced spirometers, is increasing, with the market for these products expected to grow as more clinics adopt comprehensive respiratory care solutions. Overall, the convergence of rising disease prevalence, specialized care needs, and innovative product offerings positions the specialty clinics segment for significant growth in the respiratory devices market.

By Geography, North America Holds the Largest Share in the Market Revenue
North America holds the largest share of the respiratory devices market, driven by the high prevalence of respiratory diseases, advancements in technology, and supportive government initiatives. 
• The Centers for Disease Control and Prevention (CDC) reported that in 2020, approximately 15 million adults in the U.S. were diagnosed with chronic obstructive pulmonary disease (COPD), highlighting the urgent need for effective respiratory care solutions. 
• Companies like ResMed and Koninklijke Philips N.V. are actively responding to this demand; for instance, ResMed launched its AirSense 11 CPAP device in December 2021, which features advanced algorithms to enhance patient comfort and compliance. 
• Furthermore, the U.S. government has implemented initiatives such as the National Asthma Control Program, which aims to improve asthma management through better access to care and education, thereby increasing the market for respiratory devices. 
• During 2020 and 2021, the COVID-19 pandemic has accelerated the adoption of respiratory devices, with companies like Medtronic reporting a surge in demand for ventilators and other respiratory support equipment, further solidifying the market's expansion in North America.

Key Target Audience:
• Respiratory Care Device Manufacturers and Distributors
• Healthcare Institutions 
• Specialty Clinics Focusing on Respiratory Conditions
• Research Institutes and Academic Organizations
• Contract Manufacturing Organizations (CMOS)

List of the Key Players Profiled in the Report Includes: 
• Koninklijke Philips N.V.
• Medtronic 
• ResMed, Inc. 
• Fisher & Paykel Healthcare Limited 
• Masimo 
• Getinge AG 
• GE HealthCare 
• Baxter 
• Nihon Kohden Corporation
• Welch Allyn, Inc.
• Novelda AS
• Smiths Medical
 
Recent Developments:
• In August 2024,Fisher & Paykel Healthcare Limited Launched the F&P my820 System in the United States.
• In June 2024, Baxter released a new line of respiratory therapy devices aimed at improving patient outcomes in home care settings.
• In July 2024, Nihon Kohden Corporation Launched a new line of respiratory monitoring devices designed for ICU settings.
• In June 2024, Welch Allyn, Inc. introduced a new portable spirometer aimed at improving respiratory diagnostics in outpatient settings.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Type: 
• Therapeutic Devices
• Diagnostic & Monitoring Devices
• Consumables and Accessories

Market by, Application:
• Acute Respiratory Infections
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Infectious Diseases
• Sleep Apnea
• Other Applications

Market by, End-User: 
• Home Care Settings
• Hospitals and ASCs
• Specialty Clinics
• Other End-User

Market by, Geography:
The respiratory devices market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

Table Of Content

1 Market Introduction               
    1.1 Market Definition           
    1.2 Research Scope and Segmentation           
    1.3 Stakeholders           
    1.4 List of Abbreviations           
                
2 Executive Summary               
                
3 Research Methodology               
    3.1 Identification of Data           
    3.2 Data Analysis           
    3.3 Verification           
    3.4 Data Sources           
    3.5 Assumptions           
                
4 Market Dynamics               
    4.1 Market Drivers           
    4.2 Market Restraints           
    4.3 Market Opportunities           
    4.4 Market Challenges           
                
5 Porter's Five Force Analysis               
    5.1 Bargaining Power of Suppliers           
    5.2 Bargaining Power of Buyers           
    5.3 Threat of New Entrants           
    5.4 Threat of Substitutes           
    5.5 Competitive Rivalry in the Market           
                
6 Global Respiratory Devices Market by, Type               
    6.1 Overview           
    6.2 Therapeutic Devices           
             6.2.1 Positive Airway Pressure (PAP) Devices  
             6.2.2 Airway Management Devices  
             6.2.3 Ventilators  
             6.2.4 Inhalers  
             6.2.5 Nebulizers  
             6.2.6 Other Therapeutic Devices  
    6.3 Diagnostic & Monitoring Devices           
             6.3.1 Spirometers  
             6.3.2 Polysomnography Devices  
             6.3.3 Pulse Oximeters  
             6.3.4 Other Diagnostic & Monitoring Devices  
    6.4 Consumables and Accessories           
             6.4.1 Masks  
             6.4.2 Nasal Cannula  
             6.4.3 Other Consumables and Accessories  
                
7 Global Respiratory Devices Market by, Application               
    7.1 Overview           
    7.2 Acute Respiratory Infections           
    7.3 Asthma           
    7.4 Chronic Obstructive Pulmonary Disease (COPD)           
    7.5 Infectious Diseases           
    7.6 Sleep Apnea           
    7.7 Other Applications           
                
8 Global Respiratory Devices Market by, End-User               
    8.1 Overview           
    8.2 Home Care Settings           
    8.3 Hospitals and ASCs           
    8.4 Specialty Clinics           
    8.5 Other End-Users           
                
9 Global Respiratory Devices Market by, Geography               
    9.1 Overview           
    9.2 North America           
             9.2.1 US  
             9.2.2 Canada  
             9.2.3 Mexico  
    9.3 Europe           
             9.3.1 Germany  
             9.3.2 France  
             9.3.3 UK  
             9.3.4 Italy  
             9.3.5 Spain  
             9.3.6 Rest of Europe  
    9.4 Asia Pacific           
             9.4.1 China  
             9.4.2 Japan  
             9.4.3 India  
             9.4.4 South Korea  
             9.4.5 Australia  
             9.4.6 New Zealand  
             9.4.7 Rest of Asia Pacific  
    9.5 South America           
             9.5.1 Brazil  
             9.5.2 Argentina  
             9.5.3 Chile  
             9.5.4 Rest of South America  
    9.6 Middle East & Africa           
             9.6.1 UAE  
             9.6.2 Saudi Arabia  
             9.6.3 Qatar  
             9.6.4 Iran  
             9.6.5 South Africa  
             9.6.6 Rest of Middle East & Africa  
                
10 Key Developments               
                
11 Company Profiling               
    11.1 Koninklijke Philips N.V.           
             11.1.1 Business Overview  
             11.1.2 Product/Service Offering  
             11.1.3 Financial Overview  
             11.1.4 SWOT Analysis  
             11.1.5 Key Activities  
    11.2 Medtronic            
    11.3 ResMed, Inc.            
    11.4 Fisher & Paykel Healthcare Limited            
    11.5 Masimo            
    11.6 Getinge AG            
    11.7 GE HealthCare            
    11.8 Baxter            
    11.9 Nihon Kohden Corporation           
    11.10 Welch Allyn, Inc.           
    11.11 Novelda AS           
    11.12 Smiths Medical